<DOC>
	<DOC>NCT00944671</DOC>
	<brief_summary>A study in 24 healthy subjects to assess the bioequivalence of Famotidine/Antacid EZ Chew tablet taken without water and with water compared to the Famotidine/Antacid tablet taken with water. Subjects will be given a single dose of each treatment separated by 5 to 7 days.</brief_summary>
	<brief_title>A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets (0208C-145)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<mesh_term>Antacids</mesh_term>
	<mesh_term>Magnesium Hydroxide</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<mesh_term>Anti-Ulcer Agents</mesh_term>
	<criteria>Female subject is not pregnant or lactating, Females of childbearing potential must use reliable means of contraception during the course of the study Subject is in good health Subject is able to abstain from smoking during the 24hour periods before and during each treatment day Subject has a history of stomach ulcers, other Gastrointestinal (GI) diseases or GI surgery Subject has a history of asthma or severe allergies to drugs or foods Subject currently uses prescribed or nonprescribed drugs on a regular basis Subject has a recent history of drug/alcohol abuse Subject consumes more than 6 cups of coffee per day Subject has unconventional or extreme dietary habits Subject has donated blood or has been in a clinical trial in which they received an investigational drug during the past 30 days Subject has a history of allergy or intolerance to antacids Female subject is known to be pregnant or is not using reliable means of contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>